Literature DB >> 28258443

Semi-quantitative scoring of skeletal metastases by 123I-mIBG scintigraphy in high-risk neuroblastoma.

Mark N Gaze1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28258443     DOI： 10.1007/s00259-017-3660-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  23 in total

1.  Guidelines for radioiodinated MIBG scintigraphy in children.

Authors:  Pierre Olivier; Paula Colarinha; Jure Fettich; Sibylle Fischer; Jörgen Frökier; Francesco Giammarile; Isky Gordon; Klaus Hahn; Levent Kabasakal; Mike Mann; Mercedes Mitjavila; Amy Piepsz; Ute Porn; Rune Sixt; Jeannette van Velzen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-26       Impact factor: 9.236

2.  Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.

Authors:  Igor Černý; Jiri Prášek; Helena Kašpárková
Journal:  Nuklearmedizin       Date:  2016-04-07       Impact factor: 1.379

3.  Prognostic value of ¹⁸F-DOPA PET/CT at the time of recurrence in patients affected by neuroblastoma.

Authors:  Arnoldo Piccardo; Matteo Puntoni; Egesta Lopci; Massimo Conte; Luca Foppiani; Stefania Sorrentino; Giovanni Morana; Mehrdad Naseri; Angelina Cistaro; Giampiero Villavecchia; Stefano Fanti; Alberto Garaventa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-22       Impact factor: 9.236

4.  Outcome of children with relapsed or refractory neuroblastoma: A meta-analysis of ITCC/SIOPEN European phase II clinical trials.

Authors:  Lucas Moreno; Herve Rubie; Amalia Varo; Marie Cecile Le Deley; Loredana Amoroso; Aurelie Chevance; Alberto Garaventa; Marion Gambart; Francisco Bautista; Dominique Valteau-Couanet; Birgit Geoerger; Gilles Vassal; Xavier Paoletti; Andrew D J Pearson
Journal:  Pediatr Blood Cancer       Date:  2016-08-24       Impact factor: 3.167

Review 5.  Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force.

Authors:  K K Matthay; B Shulkin; R Ladenstein; J Michon; F Giammarile; V Lewington; A D J Pearson; S L Cohn
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

6.  The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.

Authors:  Susan L Cohn; Andrew D J Pearson; Wendy B London; Tom Monclair; Peter F Ambros; Garrett M Brodeur; Andreas Faldum; Barbara Hero; Tomoko Iehara; David Machin; Veronique Mosseri; Thorsten Simon; Alberto Garaventa; Victoria Castel; Katherine K Matthay
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

Review 7.  Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Authors:  G M Brodeur; J Pritchard; F Berthold; N L Carlsen; V Castel; R P Castelberry; B De Bernardi; A E Evans; M Favrot; F Hedborg
Journal:  J Clin Oncol       Date:  1993-08       Impact factor: 44.544

8.  Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.

Authors:  Nermine O Basta; Gail C Halliday; Guy Makin; Jillian Birch; Richard Feltbower; Nick Bown; Martin Elliott; Lucas Moreno; Giuseppe Barone; Andrew Dj Pearson; Peter W James; Deborah A Tweddle; Richard Jq McNally
Journal:  Br J Cancer       Date:  2016-10-04       Impact factor: 7.640

9.  Radiosynthesis of no-carrier-added meta-[124I]iodobenzylguanidine for PET imaging of metastatic neuroblastoma.

Authors:  Michael Green; Jonathan Lowe; Manikandan Kadirvel; Adam McMahon; Nigel Westwood; Sue Chua; Gavin Brown
Journal:  J Radioanal Nucl Chem       Date:  2016-10-24       Impact factor: 1.371

10.  Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.

Authors:  Yen-Lin Liu; Meng-Yao Lu; Hsiu-Hao Chang; Ching-Chu Lu; Dong-Tsamn Lin; Shiann-Tarng Jou; Yung-Li Yang; Ya-Ling Lee; Shiu-Feng Huang; Yung-Ming Jeng; Hsinyu Lee; James S Miser; Kai-Hsin Lin; Yung-Feng Liao; Wen-Ming Hsu; Kai-Yuan Tzen
Journal:  Oncotarget       Date:  2016-04-05
View more
  1 in total

Review 1.  How rapid advances in imaging are defining the future of precision radiation oncology.

Authors:  Laura Beaton; Steve Bandula; Mark N Gaze; Ricky A Sharma
Journal:  Br J Cancer       Date:  2019-03-26       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.